B-D-Galactose

B-D-Galactose

SCHEMBL361799

O=P(O)(O)O.OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of B-D-Galactose. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LGALS1 P09382 2/20 0.48
LGALS3 P17931 2/20 0.48
LGALS9 O00182 1/20 0.48
LGALS8 O00214 1/20 0.48
CA12 O43570 3/20 0.43
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CA9 Q16790 3/20 0.43
FBP1 P09467 1/20 0.42
PYGB P11216 7/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dextrose SCHEMBL6038162 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8CA12
Beta-D-Glucose SCHEMBL361597 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8CA12
B-D-Galactose SCHEMBL16429773 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8CA12
Dextrose SCHEMBL7651668 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8CA12
D-Mannose SCHEMBL1772795 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8CA12
D-Galactose SCHEMBL17593535 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8CA12
B-D-Galactose SCHEMBL361340 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8CA12
B-D-Galactose SCHEMBL361515 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8CA12
B-D-Galactose SCHEMBL9847381 0.98 LGALS1 (0.47) LGALS1LGALS3LGALS9LGALS8CA12
Ribose (Furanose) SCHEMBL27896040 0.98 LGALS1 (0.45) LGALS1LGALS3LGALS9LGALS8CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116178461-A Cyclized phosphate sugar ester compound and application thereof 中国农业大学 2023-05-30 CN disclosed
CN-115975981-A Xanthomonas disease-resistant related protein and coding gene and application thereof 中国农业大学 2023-04-18 CN disclosed
EP-2593549-A2 METABOLICALLY ENGINEERED ORGANISMS FOR THE PRODUCTION OF ADDED VALUE BIO-PRODUCTS Universiteit Gent (BE) 2013-05-22 EP disclosed
EP-2186906-B1 Medium for detecting and differentiating vancomycin-resistant enterococci OXOID LTD (GB) 2012-07-25 EP disclosed
WO-2012007481-A2 METABOLICALLY ENGINEERED ORGANISMS FOR THE PRODUCTION OF ADDED VALUE BIO-PRODUCTS UNIVERSITEIT GENT (BE) 2012-01-19 WO disclosed
EP-2186906-A2 Medium for detecting and differentiating vancomycin-resistant enterococci OXOID LIMITED (GB) 2010-05-19 EP disclosed